Search for Clinical Trial Results
Angioedemas, Hereditary - 67 Studies Found
Status | Study |
Terminated |
Study Name: Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema Condition:
Date: 2016-01-20 Interventions: Drug: avoralstat Other Name: BCX4161 |
Active, not recruiting |
Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2014-12-10 Interventions: Biological: C1-esterase inhibitor |
Recruiting |
Study Name: Biomarker for Hereditary Angioedema Disease Type 1 Condition:
|
Completed |
Study Name: C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) Condition: Hereditary Angioedema Date: 2006-02-15 Interventions: Drug: C1 Esterase Inhibitor Lyophilisate containing approximately 500 U C1-INH to be reconstituted with |
Completed |
Study Name: Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2005-09-12 Interventions:
|
Completed |
Study Name: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema Condition: Genetic Disorders Date: 2005-12-01 Interventions: Drug: i.v. recombinant human C1 inhibitor |
Completed |
Study Name: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2006-02-07 Interventions:
|
Completed |
Study Name: C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2009-10-29 Interventions:
|
Active, not recruiting |
Study Name: Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Condition: Hereditary Angioedema Date: 2016-04-08 Interventions:
|
Completed |
Study Name: Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Condition: Hereditary Angioedema Date: 2015-10-23 Interventions:
|